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Background: Meningioangiomatosis (MA) is a rare hamartomatous lesion. Only six cases of cystic MA have been
reported in the literature.
Case presentation: We present a case of multicystic MA. A 21-year-old woman without any stigmata of
neurofibromatosis type 2 presented with intractable seizures since 10 years. Brain magnetic resonance imaging
revealed a well-defined, multicystic mass with heterogeneous signal intensity in the right temporal lobe. The patient
underwent resection of the lesion and of the epileptogenic cortex under intraoperative electrocorticography (ECoG)
assistance. Histopathological examination showed proliferation of perivascular cells that were arranged in a cuff pattern
and were positive for vimentin, D2-40 and smooth muscle actin. Mutiple microcysts and enlarged perivascular
spaces were present, which was similar to the structure of the arachnoid cavity. Hyalinized collagen fibers with
round concentric acellular eosinophilic lamellae within areas of reactive gliosis were noted for the first time in
MA. The patient was followed up without any clinical symptoms or recurrence for 2 years.
Conclusion: MA may originate from arachnoid and vascular tissue trapped in the cortical parenchyma during
brain development, and the cysts may have resulted from the gradual accumulation of cerebrospinal fluid in the
perivascular spaces of the trapped tissue. Resection of the lesion and of the epileptogenic cortex is important not
only for pathological diagnosis but also for seizure control, and intraoperative ECoG assistance is recommended.
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Meningioangiomatosis (MA) is a rare and benign congeni-
tal disorder that involves the cortex and the overlying
leptomeninges and primarily affects children and young
adults [1]. It may occur sporadically or in association
with neurofibromatosis type 2 (NF2) [2]. Approximately
120 cases of MA have been reported in the literature. Of
these, only six cases were accompanied by cystic lesions
[3-7]. We assess the clinical, eletrophysiological, imaging
and pathological features of a case of sporadic MA with
multiple microcysts, and herein, we discuss the mecha-
nisms and treatment of this disorder.* Correspondence: gm2227@sina.com; zhwang@fmmu.edu.cn
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A 21-year-old woman presented with a history of in-
tractable focal evolving to bilateral convulsive seizures
since the age of 10 years and complained of an increase
in the frequency of the seizures in the last 5 months.
Eleven years ago, she experienced a complicated febrile
seizure with left limb convulsion and unconsciousness,
which continued for 6 h; her mental status fully recovered
after 24 h. Thereafter, generalized tonic-clonic seizures
occurred almost every month, in spite of medical treatment
with carbamazepine, phenobarbital and sodium valproate.
She had no history of adverse perinatal events, develop-
mental problems or head trauma. General physical and
neurological examinations were unremarkable; she had
no stigmata or family history of NF. Inpatient continuous
video electroencephalography (EEG) revealed right tem-
poral seizure foci with significant sharp wave activity
and spike-and-slow waves complex during drowsiness
and sleep. Magnetic resonance imaging (MRI) of the
brain demonstrated a multicystic mass with low signal
intensity on T1-weighted images and high signal inten-
sity on T2-weighted images in the right temporal lobehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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spinal fluid (CSF) on T1- and T2-weighted MRI. On
fluid-attenuated inversion-recovery sequence, the lesion
appeared as heterogeneous hypointense mass. The lesion
was well-demarcated without any perifocal edema. Clinic-
ally, a dysembryoplastic lesion was suspected. The patient
underwent right temporal craniotomy and lesionectomy.
Before resection, an intraoperative electrocorticography
(ECoG) was performed over the lesion. The ECoG showed
that epileptic foci were located in the right superior
temporal gyrus, the upper part of the middle temporal
gyrus and the right hippocampus. These lesions were
resected under a surgical microscope. The patient was
discharged 13 days after the procedure without any
neurological complications. She received postoperative
treatment with antiepileptic drugs for 10 months. Her
postsurgical course was uneventful, and a 2-year follow-up
did not reveal any recurrence of the lesion.
Gross examination of the resected right temporal lobe
revealed some whitish tissue that measured 5.0 cm ×
2.5 cm× 1.5 cm and had medium consistency and multiple,
small, fluid-filled cysts. The right hippocampus showed
some whitish tissue measuring 0.8 cm × 0.5 cm × 0.5 cm.
On microscopic examination, the lesion was observed
to be located within the cortex and the underlying white
matter, with focal involvement of the overlying leptome-
ninx. Pathological examination showed unique features of
MA, including prominent proliferation of both the small
vessels (mainly capillaries and venules) and perivascular
cells, which resembled meningothelial or fibroblast cells,
arranged in whorls and cuffs (Figure 2A). Microcystic
components and enlarged perivascular spaces were
observed within or around the perivascular cell cuffs,
and some of these cysts were similar to the arachnoidFigure 1 Axial brain magnetic resonance imaging (MRI) findings. A m
(A) and high signal intensity on T2-weighted images (B) is seen in the right te
fluid on all sequences.cavity (Figure 2B). The perivascular cells showed direct
transition into the microcystic areas or enlarged spaces,
which had variable diameters and were lined with a sin-
gle layer of spindle cells, but the microcysts were not
connected with the vessels directly. Cord-like nests of
hyperplastic fibroblast-like cells were found perpendicular
to the surface of the cerebral cortex, where encephalocele
and leptomeningeal cell proliferation were present. Many
round eosinophilic nodules with a concentric arrange-
ment of acellular lamellae within reactive gliosis were
seen between the foci of perivascular cuffs; these nodules
may have represented hyalinized collagen fibers (Figure 2C).
This might have been a reactive phenomenon rather than
an intrinsic MA component. Mitotic activity, cellular atypia
and necrosis were not identified. In the right hippocampus,
neuronal degeneration and gliosis were observed.
To determine the origin of the proliferative or lesional
cells, immunohistochemical examination was performed
using the Ventana BenchMark XT system (Roche Ltd.,
Ohio, USA). Antibodies against the following antigens
were used: vimentin (clone V9; Maixin, Fuzhou, China),
smooth muscle actin (SMA, clone 1A4; Dako, Carpinteria,
CA, USA), epithelial membrane antigen (EMA, clone E29;
Maixin), cytokeratin (CK, clone AE1/AE3; Maixin), D2-40
(clone D2-40, Dako), factor VIII (Maixin), CD31 (clone
JC70A, Dako), CD34 (clone QBEnd/10; Zhongshan,
Peking, China), H-cald (clone H-cald, Dako), glial fibrillary
acidic protein (GFAP, clone GA-5; Maixin), neurofilament
(clone 2F11, Dako) and Ki-67 protein (clone MIB-1,
Dako). The perivascular cells were mainly immunoposi-
tive for vimentin and D2-40, focally or weakly positive
for SMA, EMA and CD34, and negative for CK, CD31,
H-cald, GFAP and neurofilament (Figure 2D,E and F).
The cyst walls were often immunoreactive for vimentin,ulticystic mass (arrow) with low signal intensity on T1-weighted images
mporal lobe. The cystic component was isointense with the cerebrospinal
Figure 2 Pathological findings of meningioangiomatosis (MA). (A) The cortical component of the lesion shows prominent small blood
vessels surrounded by perivascular meningothelial cell proliferation, which is the characteristic morphology of MA (hematoxylin-eosin, HE; ×100).
(B) Dilated perivascular spaces and cysts are present within the perivascular cell cuffs (HE, ×100). (C) Cord-like nests of hyperplastic spindle cells
are seen perpendicular to the surface of the cerebral cortex, where encephalocele and leptomeningeal cell proliferation are present. Hyalinized
collagen fibers appear as concentrically arranged acellular eosinophilic lamellae within areas of reactive gliosis (HE, ×100). (D) The perivascular
cells and cystic walls are focally positive for smooth muscle actin (immunohistochemistry, IHC; ×100). (E) The perivascular cells and cystic walls are
positive for D2-40 (IHC, ×200). (F) The perivascular cells are negative for H-cald (IHC, ×200).
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CD34. Immunoreactions with CD34, CD31 and factor
VIII were detected within the cytoplasm and/or the
plasmalemma of the vessels in the center of the peri-
vascular cuffs. Ki-67 staining revealed no immunoreactive
nuclei in the perivascular cells. The cerebral cortex be-
tween the perivascular cell nests was immunopositive
for GFAP, neurofilament and EMA. The final diagnosis
was multicystic MA.
Discussion
MA is a rare and benign meningovascular hamartomatous
condition that usually involves the cerebral cortex in the
frontal or temporal regions, with varying involvement ofthe overlying leptomeninges. The lesions are often associ-
ated with NF2, although the majority of cases are sporadic
[8]. Sporadic MA usually occurs as a solitary lesion in
young patients and presents with a history of intractable
seizures or persistent headaches [9,10]. In contrast, NF2-
associated MA more frequently involves multiple lesions
and is asymptomatic [11]. In some patients, MA may be
accompanied by tumors such as meningiomas, astrocyto-
mas and oligodendroglioma [12-14].
All MA lesions share common pathological features,
namely, cortical vascular proliferation and perivascular
cuffs of proliferative, spindle-shaped, meningothelial-like
cells. Although approximately 120 cases of MA have been
reported to date worldwide, only six cases of cysts within
Table 1 Summary of seven cases of cystic meningioangiomatosis
Authors Age
(yrs)/sex
Symptoms and signs Radiological findings Cyst characteristics Operation Postoperative outcome
Fedi M [3] 18/F Rapidly progressing right
hemiparesis and urinary
incontinence
Three lesions in the left frontal cortex and
subcortical white matter, a large meningioma
in the foramen magnum, bilateral acoustic
and right trigeminal neuromas
Small cysts within the lesions Resection of meningioma Died of bilateral brainstem
infarction 8 months later
Wang Y [4] 12/M Intractable seizures for
7 years
Cystic lesion in the left frontal lobe Large cyst within the lesion Lesionectomy Seizures controlled with
antiepileptic drugs for 10 months
Kobayashi
H [5]
14/M Intractable seizures for
3 years
A 2–3 cm mass containing small cysts in the
left frontal lobe; the mass was hypointense
on T1 images and isointense on T2 images
Small cysts in the
periphery of the lesion
Total removal Seizures controlled with two





Multiple cysts and a meningioma in the
right frontal lobe
Septated large multiple cysts Total removal Forgetfulness persisted; no
recurrence of the lesion for
2 years after the surgery
Park MS [7] 47/F Headache, generalized
seizures for 5 years
Round calcified masses and eccentric cysts
with edema in the left frontoparietal and
right parietal lobes
Eccentric cysts in the left lesion Total removal of the
left lesion
No seizures or headaches for
15 months after the surgery
53/M Headache, generalized
seizures for 2 years




Total removal of both frontal
and parietal lesions
No seizures or headaches for
7 months after the surgery
Author’s case 21/F Generalized complex
seizures for 11 years
Lesion showing heterogeneous signals in
the right temporal lobe
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(Table 1) [3-7]. The mean age of these seven patients
with cystic MA including our patient was 32 years
(range, 12–58 years). Except for one patient for whom
insufficient data were available, all patients had intractable
seizures or headaches for 2–11 years (mean, 6 years). In
two patients, the cysts were visible only on microscopic
examination (microcysts); in three patients, the cysts were
sufficiently large to be detected on MRI. The diagnosis of
MA was confirmed by the pathologist in all seven patients.
Wiebe et al. described the histopathological spectrum of
MA, which can be broadly classified into predominantly
cellular and predominantly vascular types [8]. In our case,
the MRI finding of a multicystic structure differentiated
the condition from ordinary MA. According to the lit-
erature [1,3,6], patients with cystic MA are older than
patients with non-cystic MA, and the interval between
symptom onset and surgery is longer in the former. We
therefore consider that cystic/microcystic MA should
be classified as a new type of MA in order to better our
understanding of this disease and achieve an accurate
preoperative diagnosis.
The mechanisms involved in the development of MA
have not yet been elucidated. MA was considered a hamar-
tomatous proliferation of meningothelial cells, blood vessels
and fibroblasts in variable proportions [4]. However, the
observation of abnormal local vascularization in some
patients has led several authors to regard MA simply as
a vascular malformation with an added meningothelial
reaction [15]. Furthermore, it has also been suggested
that these tumors do not grow or display malignant
features. Some studies have supported the opinion that
MA may be related to NF2 gene mutation because of
its concomitance with NF2 [16]. In our patient, immu-
nohistochemical examination demonstrated that the
perivascular cells had originated from arachnoid cap
cells. Considering the histopathological findings, the
patient’s age at onset and the location of the lesion, we
propose that MA is a hamartoma that results from the
trapping of arachnoid and vascular tissue in the cerebral
parenchyma during brain development, rather than a true
neoplasm. The wide spectrum of immunohistochemical
staining patterns observed in the perivascular cells in MA
lesions in the cases reported in the literature and in our
case suggests that MA originates from pluripotent cells.
The exact mechanism underlying cyst development in
MA remains controversial. It has been speculated that
cysts form due to the accumulation of CSF within the
lesion in a manner similar to the mechanism of cyst
formation in cystic meningiomas [7]; however, a com-
munication between the cysts and the subarachnoid
space has not been confirmed in MA [5]. In our patient,
the proliferation of meningothelial-like cells and loose
perivascular cells observed on the cortical surface mayhave been the early stages of the typical cystic lesion in the
deep cortex and white matter, and the cystic component
was attributable to the enlarged perivascular spaces. The
long duration of the illness supports this hypothesis. The
fact that the cysts were not connected with the vessels
and that the cyst contents were similar to those of the
arachnoid cavity demonstrated that the cysts had originated
from arachnoid tissue. Furthermore, the same immu-
noresponse of the perivascular cells, microcystic walls
and the arachnoid cavity wall suggests that pluripotent
cells differentiate into the various cell types found in MA
[17] and that the formation of cysts is an accompanying
developmental anomaly. Mechanisms such as increased
CSF pulsation, vascular ectasia, small blood vessel obstruc-
tion or abnormal arterial wall permeability may be related
to the formation of enlarged perivascular spaces, in which
CSF gradually accumulates, eventually resulting in the
formation of microcysts and cysts. This suggests that MA
originates from pluripotent arachnoidal cap cells trapped
in the cerebral cortex.
Although many cases of MA have been described, presur-
gical diagnosis remains difficult because the wide spectrum
of clinical, imaging and electrophysiological features often
impedes the clinical diagnosis [13,18,19]. Surgical resection
is important not only for seizure control but also for patho-
logical diagnosis. Wiebe et al. reported that after surgical
removal of the tumor, long-term seizures disappeared in
43% of patients, improvement occurred in 30% of patients
and antiepileptic drug administration was required in more
than 70% of patients [8]. Partial removal of the tumor
has been shown to improve symptoms, but total removal
still seems to be more effective [8,20]. In patients in whom
postoperative seizure control was not successful, extension
of the epileptic foci was found to occur with time [21]. In
our patient, ECoG revealed perilesional cortical spikes,
and epileptogenic foci were present in not only the right
temporal lobe but also the right hippocampus. Therefore,
intraoperative or extraoperative ECoG is essential for de-
tecting epileptogenic foci [22], which often exist in the ad-
jacent cortex rather than in the lesion. In the present case,
total surgical removal was achieved using intraoperative
ECoG assistance, and a favorable outcome was obtained.
Conclusion
The present case demonstrates that MA may present as a
hamartomatous lesion containing multiple microcysts in a
patient with medically refractory seizures, and should be
considered in the differential diagnosis of intracortical
lesions, especially in young adults. It is possible that MA
originates from arachnoid and vascular tissue trapped in
the cortical parenchyma during brain development, and
that the cysts result from gradual accumulation of CSF
in the perivascular spaces that develop from the trapped
tissue. Our data do not support a meningeal origin of MA,
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differentiate into the various cell types found in MA.
Resection of the lesion and of the epileptogenic cortex
is important not only for pathological diagnosis but also
for seizure control, and intraoperative ECoG assistance is
recommended.
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